Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms

Annals of Clinical Microbiology and Antimicrobials

Volumn 8, Issue , 2009, Pages

  Pettit, Robin K ^a   Weber, Christine A ^a   Pettit, George R ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE; ALAMAR BLUE DYE; BACITRACIN; BLUE DYE; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CONFLIKT; DYE; ENROFLOXACIN; GENTAMICIN; LYSOSTAPHIN; NITROFURAL; OXACILLIN; PENICILLIN G; PURPLE DYE; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN; 2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 5 ((PHENYLAMINO)CARBONYL) 2H TETRAZOLIUM HYDROXIDE; 2,3-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-5-((PHENYLAMINO)CARBONYL)-2H-TETRAZOLIUM HYDROXIDE; ANTIINFECTIVE AGENT; DIAGNOSTIC AGENT; OXAZINE DERIVATIVE; RESAZURIN; TETRAZOLIUM; XANTHENE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIABILITY; BACTERIUM ISOLATE; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATION REDUCTION REACTION; RELIABILITY; REPRODUCIBILITY; SPECTROSCOPY; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; EVALUATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; STATISTICS;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OXAZINES; OXIDATION-REDUCTION; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCUS AUREUS; STATISTICS AS TOPIC; TETRAZOLIUM SALTS; XANTHENES;

EID: 71149113591     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-8-28     Document Type: Article

References (27)

1. Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 2001, 49:87-93. 10.1053/jhin.2001.1052, 11567552.
2. Stamm WE. Prevention of infections. Infections related to medical devices. Ann Intern Med 1978, 89:764-69.
3. Maki DG. Infections due to infusion therapy. Hospital Infections 1992, 849-898. Boston, MA: Little, Brown and Co, Bennett JV, Brachman PS.
4. Moreillon P, Que YA. Infective endocarditis. Lancet 2004, 363:139-49. 10.1016/S0140-6736(03)15266-X, 14726169.
5. Waldvogel FA, Bisno AL. Infections associated with indwelling medical 2000,
6. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Eng J Med 2004, 351:1645-54.
7. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-93. 10.1128/CMR.15.2.167-193.2002, 118068, 11932229.
8. Stewart PS, Mukherjee PK, Ghannoum MA. Biofilm antimicrobial resistance. Microbial Biofilms 2004, 250-268. Washington DC: ASM Press, Ghannoum M, O'Toole GA.
9. Amorena B, Gracia E, Monzón M, Leiva J, Oteiza C, Pérez M, Alabart J, Hernández-Yago J. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 1999, 44:43-55. 10.1093/jac/44.1.43, 10459809.
10. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999, 37:1771-76. 84946, 10325322.
11. Hodson AE, Nelson SM, Brown M, Gilbert P. A simple in vitro model for growth control of bacterial biofilms. J Appl Bacteriol 1995, 79:87-93.
12. Kharazmi A, Giwercman B, Holby N. Robbins device in biofilm research. Meth Enzym 1999, 310:207-215. full_text, 10547794.
13. Polonio RE, Mermel LA, Paquette GE, Sperry JF. Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin. Antimicrob Agents Chemother 2001, 45:3262-66. 10.1128/AAC.45.11.3262-3266.2001, 90822, 11600396.
14. Pettit RK, Weber CA, Kean MJ, Hoffman H, Pettit GR, Tan R, Franks KS, Horton ML. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chem 2005, 49:2612-17.
15. Repp KK, Menor SA, Pettit RK. Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms. Med Mycol 2007, 45:603-07. 10.1080/13693780701581458, 17885957.
16. Cassat JE, Lee CY, Smeltzer MS. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods in Molecular Biology 2007, 127-144. Humana Press, Kropsinski AM, Totowa NJ.
17. Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol 2008, 74:470-76. 10.1128/AEM.02073-07, 2223269, 18039822.
18. O'Gara JP. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 2007, 270:179-88. 10.1111/j.1574-6968.2007.00688.x, 17419768.
19. Hawser SP, Douglas J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994, 62:915-21. 186203, 8112864.
20. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002, 70:878-88. 10.1128/IAI.70.2.878-888.2002, 127692, 11796623.
21. Kuhn DM, Balkis M, Chandra J, Mukherjee PK, Ghannoum MA. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin 2003, 41:506-08.
22. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7-A5. 2000, Villanova, PA: NCCLS, 4.
23. Schindler C, Schuhardt V. Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA 1964, 51:414-21. 10.1073/pnas.51.3.414, 300087, 14171453.
24. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003, 47:3407-14. 10.1128/AAC.47.11.3407-3414.2003, 253758, 14576095.
25. Shah A, Mond J, Walsh S. Lysostaphin-coated catheters eradicate Staphylococcus aureus challenge and block surface colonization. Antimicrob Agents Chemother 2004, 48:2704-07. 10.1128/AAC.48.7.2704-2707.2004, 434171, 15215130.
26. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Meth 2008, 72:157-65.
27. Sandberg M, Määttänen A, Peltonen J, Vuorela PM, Fallarero A. Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: an approach to screening of natural antimicrobial compounds. Int J Antimicrob Agents 2008, 32:233-40. 10.1016/j.ijantimicag.2008.04.022, 18640013.